Logo

Genomatix Expands Software-use Agreement with NIH

Aug 14, 2003

NEW YORK, Aug. 14 (GenomeWeb News) - Genomatix today said that researchers from the National Cancer Institute, the National Institute of Arthritis and Musculoskeletal and Skin Disease, and the National Heart, Blood, and Lung Institute have signed up for unlimited access to its software.

 

A Genomatix spokesman said "several more" institute orders are pending.

 

Currently, more than 150 researchers from the US National Institutes of Health are using gratis Genomatix's on-line services of integrated in silico systems biology tools.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.